CABG术后5年内非致死性事件对10年结局的影响
该单中心研究纳入1990至2014年接受择期首次单纯CABG且5年时存活的患者20444例,其中11%在术后5年内发生非致死性MACCE。倾向性评分匹配后形成2167对患者,非MACCE组10年总生存优于MACCE组(HR 1.42;95%CI 1.25-1.63;P<.01),无MACCE生存亦更优(HR 1.61;95%CI 1.45-1.79;P<.01)。
要点
- CABG术后5年内11%患者发生非致死性MACCE,其中44.9%为心梗、24.0%为卒中、43.7%需再次血运重建。
- 匹配后非MACCE组10年总生存优于MACCE组(HR 1.42;95%CI 1.25-1.63;P<.01)。
- 非MACCE组10年无MACCE生存亦优于MACCE组(HR 1.61;95%CI 1.45-1.79;P<.01)。
核心结论
- CABG术后5年内发生非致死性MACCE的患者10年生存更差且MACCE更多。
- 预防外科血运重建后5年内主要不良事件可能是改善远期结局的重要策略。
研究设计与样本
- 回顾性纳入1990至2014年加拿大安大略省单中心所有接受单纯CABG的患者。
- 共20444例择期首次单纯CABG且5年时存活者进入分析,倾向性评分匹配后形成2167对患者。
- 主要终点为全因死亡,次要终点为MACCE(死亡、非致死性心梗、卒中及再次血运重建的复合终点)。
主要发现
- 5年内11%患者发生非致死性MACCE(MACCE组),其余89%为5年时无MACCE事件存活(非MACCE组)。
- MACCE组2167例中972例(44.9%)发生心梗、519例(24.0%)发生卒中、946例(43.7%)需再次血运重建。
- 非MACCE组10年总生存优于MACCE组(HR 1.42;95%CI 1.25-1.63;P<.01)。
- 非MACCE组10年无MACCE生存优于MACCE组(HR 1.61;95%CI 1.45-1.79;P<.01)。
临床怎么用
- CABG术后5年内发生非致死性MACCE的患者10年生存更差且MACCE更多。
- 预防外科血运重建后5年内主要不良事件可能是改善远期结局的重要策略。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Few have examined the influence of early adverse events after coronary artery bypass grafting (CABG) on long-term survival. We sought to determine if the occurrence of nonfatal major adverse cardiac and cerebrovascular events (MACCE) during the first 5 years after CABG influences survival and adverse events at 10 years. METHODS: All patients who underwent isolated CABG from 1990 to 2014 at a single center in Ontario, Canada, were included. Primary end point was all-cause mortality. The secondary end point of interest was MACCE, a composite of mortality, nonfatal myocardial infarction, stroke, and repeat revascularization. RESULTS: A total of 20,444 cases of elective primary isolated CABG were identified as being alive at 5 years, with 11% of patients developing nonfatal MACCE within the first 5 years after CABG (MACCE group) and the remaining 89% were alive without a MACCE event at 5 years (non-MACCE group). Following propensity score matching, 2167 patient-pairs were formed. Among the MACCE group, 972 out of 2167 (44.9%) developed a myocardial infarction, 519 out of 2167 (24.0%) had a stroke, and 946 out of 2167 (43.7%) required a repeat revascularization within the first 5 years after CABG. Non-MACCE was associated with better overall survival (hazard ratio, 1.42; 95% CI, 1.25-1.63; P < .01) and freedom from MACCE (hazard ratio, 1.61; 95% CI, 1.45-1.79; P < .01) up to 10 years after CABG compared with MACCE cases. CONCLUSIONS: Patients who experienced nonfatal MACCE during the first 5 years after CABG experienced worse survival and more MACCE at 10 years. Prevention of major adverse events during the first 5 years after surgical revascularization may be an important strategy to improve late outcomes.
引用
- Rocha RV, Yau TM, Chu A, et al. Do nonfatal events during the first 5 years after coronary artery bypass surgery influence 10 year outcomes? J Thorac Cardiovasc Surg. 2024. PMID: 39332522. doi:10.1016/j.jtcvs.2024.09.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。